ZYMERON
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 09 Oct 2025)
What this means for you
Registered since 23 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88257580
- Registration number
- 5813236
- Mark type
- Stylized text
- Filed
- 10 Jan 2019
- Published for opposition
- 07 May 2019
- Registered
- 23 Jul 2019
- Attorney of record
- Steven J. Hultquist
Goods and services
- Class 042 — Scientific and technological services: Product research and development; scientific research and development; biochemical research and development; pharmaceutical research and development; research and development of new products; research and development of new products for others; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of antibodies; research and development of new products for third parties in the fields of plastic materials; research and development of technology and products in the fields of nanomaterials, polymer materials, polymer-based biomaterials, biopolymers, in vitro diagnostics tests, sample collection techniques and devices, drug delivery formulations, pharmaceutical dose forms, pharmaceutical devices, drug formulations, dermatological products, biological drugs, immunotherapy agents, protein purification materials and agents, coatings, and medical devices; consulting services in the fields of biotechnology, pharmaceutical research and development, genetic sciences, laboratory testing, diagnostics, and pharmacogenetics; consulting services in the fields of nanomaterials, polymer materials, polymer-based biomaterials, biopolymers, in vitro diagnostics tests, sample collection techniques and devices, drug delivery formulations, pharmaceutical dose forms, pharmaceutical devices, drug formulations, dermatological products, biological drugs, immunotherapy agents, protein purification materials and agents, coatings, and medical devices; research and development in the fields of nanomaterials, polymer materials, polymer-based biomaterials, biopolymers, in vitro diagnostics tests, sample collection techniques and devices, drug delivery formulations, pharmaceutical dose forms, pharmaceutical devices, drug formulations, dermatological products, biological drugs, immunotherapy agents, protein purification materials and agents, coatings, and medical devices; design, engineering, research, development, and testing services in the field of polymeric materials, polymers synthesis, and materials customization for medical, scientific, and technological applications
Owner
- Zymeron Corporation, Durham, NC, US
- Zymeron Corporation, Durham, NC, US
- Zymeron Corporation, Durham, NC, US
Prosecution history
- 09 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Jun 2025 — TEAS SECTION 8 & 15 RECEIVED
- 23 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 07 May 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2019 — PUBLISHED FOR OPPOSITION
- 17 Apr 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Mar 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2019 — ASSIGNED TO EXAMINER
- 01 Feb 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Jan 2019 — NEW APPLICATION ENTERED